BR0010681A - Macrolide anti-infectious agents - Google Patents

Macrolide anti-infectious agents

Info

Publication number
BR0010681A
BR0010681A BR0010681-0A BR0010681A BR0010681A BR 0010681 A BR0010681 A BR 0010681A BR 0010681 A BR0010681 A BR 0010681A BR 0010681 A BR0010681 A BR 0010681A
Authority
BR
Brazil
Prior art keywords
substituted
unsubstituted
amino
alkyl
infectious agents
Prior art date
Application number
BR0010681-0A
Other languages
Portuguese (pt)
Inventor
Daniel T W Chu
Original Assignee
Kosan Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kosan Biosciences Inc filed Critical Kosan Biosciences Inc
Priority claimed from US09/551,162 external-priority patent/US6451768B1/en
Priority claimed from PCT/US2000/009915 external-priority patent/WO2000063225A2/en
Publication of BR0010681A publication Critical patent/BR0010681A/en

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Patente de Invenção: "AGENTES ANTIINFECCIOSOS DE MACROLIDO". Composto da fórmula (1), (2) ou (3) ou as formas 10, 11 anidro dos mesmos, onde: R~ a~ é H ou OH, preferivelmente OH; R~ b~ é H ou halogênio; R~ c~ é H ou um grupo de proteção; R~ d~ é metila; (3-10C) alquila não substituída; (1-10C) alquila substituída; (2-10C) alquenila substituída ou não substituída; (2-10C) alquinila substituída ou não substituída; (4-14C) arila substituída ou não substituída; (5-20C) arilalquila substituída ou não substituída; (5-20C) arilalquenila substituída ou não substituída; (5-20C) arilalquinila substituída ou não substituída; (5-20C) amidoarilalquila substituída ou não substituída; (5-20C) amidoarilalquenila substituída ou não substituída; (5-20C) amidoarilalquinila substituída ou não substituída; R~ e~ é H ou um grupo de proteção ou é carbonila amino mono ou dissubstituída; R~ f~ é H; (1-10C) alquila substituída ou não substituída; (1-10C) alquenila substituída ou não substituída; (110C)alquinila substituída ou não substituída; (4-14C) arila substituída ou não substituída; (5-20C) arilaquila substituída ou não substituída; ou OR~ f~ pode ser substituído por H; um de Z e Y é H e o outro é OH ou OH protegido ou é amino, mono ou dialquilamino, amino protegido ou um aminoheterociclo ou Z e Y em conjunto são =O, =NOH ou uma oxima derivatizada; incluindo quaisquer sais farmaceuticamente aceitáveis e quaisquer formas estereoisoméricas e misturas de formas estereoisoméricas dos mesmos sendo agentes antimicrobianos.Invention Patent: "MACROLIDE ANTI-INFECTIOUS AGENTS". A compound of the formula (1), (2) or (3) or the anhydrous forms 10, 11, where: R ~ a ~ is H or OH, preferably OH; R ~ b ~ is H or halogen; R ~ c ~ is H or a protecting group; R ~ d ~ is methyl; (3-10C) unsubstituted alkyl; (1-10C) substituted alkyl; (2-10C) substituted or unsubstituted alkenyl; (2-10C) substituted or unsubstituted alkynyl; (4-14C) substituted or unsubstituted aryl; (5-20C) substituted or unsubstituted arylalkyl; (5-20C) substituted or unsubstituted arylalkenyl; (5-20C) substituted or unsubstituted arylalkynyl; (5-20C) substituted or unsubstituted amidoarylalkyl; (5-20C) substituted or unsubstituted amidoarylalkenyl; (5-20C) substituted or unsubstituted amidoarylalkynyl; R ~ and ~ is H or a protecting group or is mono- or disubstituted amino carbonyl; R ~ f ~ is H; (1-10C) substituted or unsubstituted alkyl; (1-10C) substituted or unsubstituted alkenyl; (110C) substituted or unsubstituted alkynyl; (4-14C) substituted or unsubstituted aryl; (5-20C) substituted or unsubstituted arylalkyl; or OR ~ f ~ can be replaced by H; one of Z and Y is H and the other is OH or OH protected or is amino, mono or dialkylamino, protected amino or an amino heterocycle or Z and Y together are = O, = NOH or a derivatized oxime; including any pharmaceutically acceptable salts and any stereoisomeric forms and mixtures of stereoisomeric forms thereof being antimicrobial agents.

BR0010681-0A 1999-04-16 2000-04-14 Macrolide anti-infectious agents BR0010681A (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US12972999P 1999-04-16 1999-04-16
US14017599P 1999-06-18 1999-06-18
US17215499P 1999-12-17 1999-12-17
US17215999P 1999-12-17 1999-12-17
US17380499P 1999-12-30 1999-12-30
US17380599P 1999-12-30 1999-12-30
US09/551,162 US6451768B1 (en) 1999-04-16 2000-04-14 Macrolide antiinfective agents
PCT/US2000/009915 WO2000063225A2 (en) 1999-04-16 2000-04-14 Macrolide antiinfective agents

Publications (1)

Publication Number Publication Date
BR0010681A true BR0010681A (en) 2002-02-05

Family

ID=27568858

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010681-0A BR0010681A (en) 1999-04-16 2000-04-14 Macrolide anti-infectious agents

Country Status (8)

Country Link
EP (1) EP1171448A2 (en)
JP (1) JP2003523939A (en)
CN (1) CN1636008A (en)
BR (1) BR0010681A (en)
CA (1) CA2369886A1 (en)
IL (1) IL145776A0 (en)
MX (1) MXPA01010529A (en)
NZ (1) NZ514791A (en)

Also Published As

Publication number Publication date
JP2003523939A (en) 2003-08-12
EP1171448A2 (en) 2002-01-16
CA2369886A1 (en) 2000-10-26
MXPA01010529A (en) 2002-03-14
NZ514791A (en) 2004-02-27
CN1636008A (en) 2005-07-06
IL145776A0 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
BR0010680A (en) Anti-infectious macrolide agents
BR0315781A (en) Composition for treating infection caused by virus flaviviridae
TW200630378A (en) Macrolones-amino substituted quinolones
BR0109851A (en) Compound, method for producing the same or a salt thereof, prodrug, pharmaceutical composition, method for inhibiting tyrosine kinase, method for preventing or treating cancer, and use of a compound or salt or prodrug thereof
BR0114763A (en) Antibacterial Ketolides
BR0206266A (en) Substituted diphenyl heterocyclics useful for treating hcv infection
BR0210357A (en) Compound and methods for the treatment or prevention of flavivirus infections
ATE264852T1 (en) QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
BR0316771A (en) Compounds for the treatment or prevention of flavivirus infections, use of a compound and pharmaceutical composition
BR0113389A (en) Compounds that inhibit factor xa activity
NO20071117L (en) Substituted propenyl-piperazine derivatives as novel inhibitors of histone deacetylase
HUP0500478A2 (en) Antitumor compositions containing taxane derivatives
BR0210028A (en) Antibacterial agents
BRPI0417345A (en) azole-based kinase inhibiting compounds, compositions and their uses
BR0214842A (en) Hiv integrase inhibitors
BRPI0413964A (en) quinolone carboxylic acid derivative, its composition and antibacterial agent
DK1132392T3 (en) Ketolide antibiotics
MXPA04003611A (en) Piperidine- and piperazineacetamines as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases.
BR0010681A (en) Macrolide anti-infectious agents
ATE254098T1 (en) COMPOUNDS THAT INHIBIT TRYPTASE ACTIVITY
WO2003024407A3 (en) Inhibitors of rnase p proteins as antibacterial compounds
DE69931378D1 (en) CHINAZOLINE DERIVATIVES AND THERAPEUTIC USES THEREOF
BR0006299A (en) Derivatives of 4-oxo-2-urea-1,4,5,6-tetrahydro-pyrimidine
BR0307266A (en) Compounds that inhibit factor xa activity

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]